Riskpilot← Back to searchSign inGet full accessNil Medical AB
ABActiveOrg 5592746720Tvistevägen 48 CWholesale of pharmaceutical and medical goods · NACE 4646Est. 20201-4 employees
Revenue 2024
SEK 0
EBITDA margin
—
+50% vs 2023
Equity ratio
2.7%
Financial strength
Net profit 2024
SEK -3K
+50% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -3K | +50% |
| Net profit | SEK -3K | +50% |
| Total assets | SEK 585K | +2240% |
| Equity | SEK 16K | -16% |
| Employees | — | — |
Legal name
Nil Medical AB
Org number
5592746720
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2 oktober 2020
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är utveckling, produktion och försäljning av medicinsk tekniska produkter och tjänster samt därmed förenlig verksamhet.
Address
Tvistevägen 48 C
Email
martin.hanberger@nilmedical.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −1 | −36 | −6 | −3 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −1 | −36 | −6 | −3 |
| Net financials | — | — | — | — |
| Profit before tax | −1 | −36 | −6 | −3 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −1 | −36 | −6 | −3 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 25 | 25 | 25 | 585 |
| Equity | 24 | 25 | 19 | 16 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 1 | 0 | 6 | 569 |
| Total debt | 1 | — | 6 | 569 |
EBITDA margin
-300000.0%
This company
15.8%
Market median
-1898834% vs market
20212024
Equity ratio
2.7%
This company
38.2%
Market median
-93% vs market
20212024
Return on equity
-18.8%
This company
18.4%
Market median
-202% vs market
20212024
Net profit margin
-300000.0%
This company
8.1%
Market median
-3703804% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
35.56×
This company
0.62×
Market median
-5635% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MK Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2026 | |
| Chairman | 2026 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Martin Hanberger AB
Nil Medical AB Board members of Nil Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Kristina Walfridsson | Chief Executive Officer | 0 companies |
| Asli Togan Tekin | Deputy Board Member | 0 companies |
| José Bertil Gonzalez Guve | Board of Directors | 0 companies |
| Camilla Birgitta Jansdotter Oldgren | Chairman | 0 companies |
| Asli Togan Tekin | Deputy Board Member | 0 companies |
| Martin Anders Gustav Hanberger | Board of Directors | 0 companies |